Imfinzi (Durvalumab) Injection (IV infusion vial)
Imfinzi is durvalumab, a PD-L1 blocking immunotherapy given by intravenous infusion under oncology supervision. This page explains access, cold-chain shipping and the vials we stock — the live price and checkout stay on the product pages.
Live price and checkout stay on the shop page so existing product listings are not duplicated.
Authentic Durvalumab
Named packs with batch traceability. We do not relabel generics as originators.
Storage
2–8°C refrigerated; protect from light, do not freeze
Tracked shipping
Worldwide courier to USA, UK, UAE, EU, Australia and more.
Pharmacist support
24/7 guidance from Critical Kare Pharma for patients and caregivers.
What is Imfinzi (Durvalumab)?
Durvalumab blocks PD-L1 so the immune system can recognise certain cancer cells.
Patients search both Imfinzi and durvalumab. They are the same active ingredient; 500mg/10ml and 120mg/2.4ml are different vial sizes.
Infusion schedule and monitoring for immune-related side effects are managed by the oncology team.
Class: PD-L1 immune checkpoint inhibitor. AstraZeneca (originator).
Typical uses (as prescribed)
- Non-small cell lung cancer (as indicated)
- Small cell lung cancer, extensive stage (as indicated)
- Biliary tract and other cancers where approved on the local label
Packs in our catalog
These links go to the existing product pages (unchanged URLs).
Imfinzi by country
Country hubs already rank for local searches — we link them rather than creating duplicate shop pages.
Imfinzi FAQs
Is durvalumab the same as Imfinzi?
Which Imfinzi vial do I need?
How is Imfinzi shipped?
Continue to the Imfinzi product page
Availability and USD pricing live only on the shop SKU so current Google product listings stay intact.
Information and pharmacy-access support only — not medical advice, diagnosis, or a treatment plan. Always follow your oncologist. Prescription required for oncology medicines.